RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
RT @Kristel_GT: Strategies for improving the management of #immune-related adverse events. @NicoleKuderer @Dr_Ivanoncologo @FatimaAmirCGC…
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
Strategies for improving the management of #immune-related adverse events. @NicoleKuderer @Dr_Ivanoncologo @FatimaAmirCGC @cancermex @BETZABE100 @SaraGutierrezEn https://t.co/LkminlTqz9 https://t.co/vg6Dgr2LpY
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
RT @LabNaing: We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvem…
We have made significant strides in understanding and managing irAEs effectively. However, there is room for further improvement. https://t.co/4Lbjlt5hmI by @ANaingMD , @HajjarJoud @gulleyj1 and colleagues.@OncoAlert https://t.co/8c5B8jSoHN
RT @Sinchita_Roy: Best practices to manage immune-related adverse events #checkpointinhibitor therapy @MDAndersonNews @ANaingMD @HajjarJoud
RT @project_ronin: New, important research on mitigating immune-related adverse events (irAEs). Proud to be a small part and excited to see…
RT @project_ronin: New, important research on mitigating immune-related adverse events (irAEs). Proud to be a small part and excited to see…
RT @project_ronin: New, important research on mitigating immune-related adverse events (irAEs). Proud to be a small part and excited to see…
RT @project_ronin: 10 strategies to manage immune-related adverse events from @ANaingMD & Co. Thanks for the shoutout! We're proud to be a…
RT @project_ronin: New, important research on mitigating immune-related adverse events (irAEs). Proud to be a small part and excited to see…
RT @Sinchita_Roy: Best practices to manage immune-related adverse events #checkpointinhibitor therapy @MDAndersonNews @ANaingMD @HajjarJoud
RT @Sinchita_Roy: Best practices to manage immune-related adverse events #checkpointinhibitor therapy @MDAndersonNews @ANaingMD @HajjarJoud
RT @Sinchita_Roy: Best practices to manage immune-related adverse events #checkpointinhibitor therapy @MDAndersonNews @ANaingMD @HajjarJoud…
RT @Sinchita_Roy: Best practices to manage immune-related adverse events #checkpointinhibitor therapy @MDAndersonNews @ANaingMD @HajjarJoud
RT @Sinchita_Roy: Best practices to manage immune-related adverse events #checkpointinhibitor therapy @MDAndersonNews @ANaingMD @HajjarJoud
RT @Sinchita_Roy: Best practices to manage immune-related adverse events #checkpointinhibitor therapy @MDAndersonNews @ANaingMD @HajjarJoud
Best practices to manage immune-related adverse events #checkpointinhibitor therapy @MDAndersonNews @ANaingMD @HajjarJoud
RT @MingxuanXu1: @medpagetoday highlights https://t.co/5pg6g36Fj7 regarding managing irAEs https://t.co/CG4Qg3Esk4 by @AnaingMD et al. @MD…
RT @MingxuanXu1: @medpagetoday highlights https://t.co/5pg6g36Fj7 regarding managing irAEs https://t.co/CG4Qg3Esk4 by @AnaingMD et al. @MD…
RT @MingxuanXu1: @medpagetoday highlights https://t.co/5pg6g36Fj7 regarding managing irAEs https://t.co/CG4Qg3Esk4 by @AnaingMD et al. @MD…
@medpagetoday highlights https://t.co/5pg6g36Fj7 regarding managing irAEs https://t.co/CG4Qg3Esk4 by @AnaingMD et al. @MDAndersonNews
RT @SuzieSiegel: This paper calls for more involvement of patients to understand side effects from #immunotherapy. #Sarcoma patients: Pleas…
RT @Daver_Leukemia: Outstanding effort by Dr Naing and colleagues. We really need to understand how to identify, manage and potentially pre…
RT @Daver_Leukemia: Outstanding effort by Dr Naing and colleagues. We really need to understand how to identify, manage and potentially pre…
RT @Daver_Leukemia: Outstanding effort by Dr Naing and colleagues. We really need to understand how to identify, manage and potentially pre…
RT @Daver_Leukemia: Outstanding effort by Dr Naing and colleagues. We really need to understand how to identify, manage and potentially pre…
RT @Daver_Leukemia: Outstanding effort by Dr Naing and colleagues. We really need to understand how to identify, manage and potentially pre…
Outstanding effort by Dr Naing and colleagues. We really need to understand how to identify, manage and potentially predict irAEs in Heme malignancies. Major area of unmet need @jitcancer @sitcancer @LeukemiaMDA
RT @project_ronin: 10 strategies to manage immune-related adverse events from @ANaingMD & Co. Thanks for the shoutout! We're proud to be a…
RT @jitcancer: New #JITC article: Strategies for improving the management of immune-related adverse events @ANaingMD https://t.co/FUG4APbaTc
RT @jitcancer: New #JITC article: Strategies for improving the management of immune-related adverse events @ANaingMD https://t.co/FUG4APbaTc
RT @project_ronin: 10 strategies to manage immune-related adverse events from @ANaingMD & Co. Thanks for the shoutout! We're proud to be a…
RT @project_ronin: 10 strategies to manage immune-related adverse events from @ANaingMD & Co. Thanks for the shoutout! We're proud to be a…
RT @MingxuanXu1: We echo @JyotiBajpai01 & @NicoleKuderer. The article by @AnaingMD and coauthors ( https://t.co/sWHAvaDkrC ) calls for gl…
RT @jitcancer: New #JITC article: Strategies for improving the management of immune-related adverse events @ANaingMD https://t.co/FUG4APbaTc
RT @MingxuanXu1: We echo @JyotiBajpai01 & @NicoleKuderer. The article by @AnaingMD and coauthors ( https://t.co/sWHAvaDkrC ) calls for gl…
RT @MingxuanXu1: We echo @JyotiBajpai01 & @NicoleKuderer. The article by @AnaingMD and coauthors ( https://t.co/sWHAvaDkrC ) calls for gl…
RT @jitcancer: New #JITC article: Strategies for improving the management of immune-related adverse events @ANaingMD https://t.co/FUG4APbaTc
RT @MingxuanXu1: We echo @JyotiBajpai01 & @NicoleKuderer. The article by @AnaingMD and coauthors ( https://t.co/sWHAvaDkrC ) calls for gl…
Fantastic Work!!
RT @JyotiBajpai01: Great article and very timely !!high time we must have global collaborations and recommendations to improve upon strateg…
RT @MingxuanXu1: We echo @JyotiBajpai01 & @NicoleKuderer. The article by @AnaingMD and coauthors ( https://t.co/sWHAvaDkrC ) calls for gl…
RT @jitcancer: New #JITC article: Strategies for improving the management of immune-related adverse events @ANaingMD https://t.co/FUG4APbaTc
RT @MingxuanXu1: We echo @JyotiBajpai01 & @NicoleKuderer. The article by @AnaingMD and coauthors ( https://t.co/sWHAvaDkrC ) calls for gl…
We echo @JyotiBajpai01 & @NicoleKuderer. The article by @AnaingMD and coauthors ( https://t.co/sWHAvaDkrC ) calls for global collaboration to mitigate irAEs @oncology_bg @ @OncoAlert @EmergencyDocs
RT @jitcancer: New #JITC article: Strategies for improving the management of immune-related adverse events @ANaingMD https://t.co/FUG4APbaTc
RT @gedefo_sefh: Strategies for improving the management of immune-related adverse events https://t.co/XlIDEFVuIg
RT @jitcancer: New #JITC article: Strategies for improving the management of immune-related adverse events @ANaingMD https://t.co/FUG4APbaTc
RT @jitcancer: New #JITC article: Strategies for improving the management of immune-related adverse events @ANaingMD https://t.co/FUG4APbaTc
RT @jitcancer: New #JITC article: Strategies for improving the management of immune-related adverse events @ANaingMD https://t.co/FUG4APbaTc
RT @jitcancer: New #JITC article: Strategies for improving the management of immune-related adverse events @ANaingMD https://t.co/FUG4APbaTc
RT @jitcancer: New #JITC article: Strategies for improving the management of immune-related adverse events @ANaingMD https://t.co/FUG4APbaTc
New #JITC article: Strategies for improving the management of immune-related adverse events @ANaingMD https://t.co/FUG4APbaTc
Great article and very timely !!high time we must have global collaborations and recommendations to improve upon strategies for improving irAEs!@peters_solange @oncology_bg @HaanenJohn @tompowles1 @Alfdoc2 @wolchokj @RimaPathak1 @DrAtulSharma10 @SilviaStac
Strategies for improving the management of immune-related adverse events https://t.co/XlIDEFVuIg
RT @ANaingMD: https://t.co/4pZMdN2s2B with @HajjarJoud @bcmhouston @gulleyj1 @NCICCR_GMB @NCICCR_MOS, Michael B. Atkins @LombardiCancer, @G…
RT @Mike_VanAlstine: New and modern strategies for managing the delivery of IO therapy and associated toxicities. Very nice article.
RT @SirohiBhawna: Practical recommendations ! Very well written @ANaingMD @OncoAlert @ASCOPost @myESMO congratulations!
RT @Mike_VanAlstine: New and modern strategies for managing the delivery of IO therapy and associated toxicities. Very nice article.
New and modern strategies for managing the delivery of IO therapy and associated toxicities. Very nice article.
RT @Al3ssandroRusso: Excellent paper of @ANaingMD and colleagues on strategies for improving the management of irAEs
RT @DrYukselUrun: Excellent recommendation/Strategies for improving the management of immune-related adverse events (irAEs)! @ANaingMD @ji…
RT @DrYukselUrun: Excellent recommendation/Strategies for improving the management of immune-related adverse events (irAEs)! @ANaingMD @ji…
RT @SirohiBhawna: Practical recommendations ! Very well written @ANaingMD @OncoAlert @ASCOPost @myESMO congratulations! https://t.co/z9AVJu…
Practical recommendations ! Very well written @ANaingMD @OncoAlert @ASCOPost @myESMO congratulations!
RT @DrYukselUrun: Excellent recommendation/Strategies for improving the management of immune-related adverse events (irAEs)! @ANaingMD @ji…
RT @FasaAgbedia: Strategies to improve our understanding and management of immune-related adverse events in the era of immunotherapy in ord…
RT @Dr_R_Kurzrock: Strategies for improving the management of immune-related adverse events | Journal for ImmunoTherapy of Cancer: NaingLa…
RT @GennaroCiliber1: Porto alla attenzione il nostro nuovo lavoro sulla gestione degli eventi avversi da #immunoterapia https://t.co/jAZVd6…
RT @SuzieSiegel: This paper calls for more involvement of patients to understand side effects from #immunotherapy. #Sarcoma patients: Pleas…
RT @Dr_R_Kurzrock: Strategies for improving the management of immune-related adverse events | Journal for ImmunoTherapy of Cancer: NaingLa…
RT @BoschBarrera: Hay que mejorar nuestro conocimiento y protocolos para identificar y tratar correctamente los eventos adversos inmunorela…
RT @Dr_R_Kurzrock: Strategies for improving the management of immune-related adverse events | Journal for ImmunoTherapy of Cancer: NaingLa…
RT @DrYukselUrun: Excellent recommendation/Strategies for improving the management of immune-related adverse events (irAEs)! @ANaingMD @ji…
RT @Daver_Leukemia: Outstanding review by Dr Naing and colleagues!
RT @BoschBarrera: Hay que mejorar nuestro conocimiento y protocolos para identificar y tratar correctamente los eventos adversos inmunorela…
RT @SuzieSiegel: This paper calls for more involvement of patients to understand side effects from #immunotherapy. #Sarcoma patients: Pleas…
RT @BoschBarrera: Hay que mejorar nuestro conocimiento y protocolos para identificar y tratar correctamente los eventos adversos inmunorela…
Hay que mejorar nuestro conocimiento y protocolos para identificar y tratar correctamente los eventos adversos inmunorelacionados causados por la inmunoterapia. Gran artículo proponiendo diversas medidas al respecto.
RT @JyotiBajpai01: My heartiest congratulations to Aung Naing, Joud Hajjar and entire Group for this very informative paper!!
RT @ad1600: Excellent summation of irAEs!
RT @Al3ssandroRusso: Excellent paper of @ANaingMD and colleagues on strategies for improving the management of irAEs
RT @DRCagatayOzturk: Tebrikler-congrats